PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Weight Loss D015431 56 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Leukemia P388 D007941 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hyperalgesia D006930 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Kawabe Y et al. Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. 1989 Am. J. Gastroenterol. pmid:2916522
Sakai T et al. Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. 1989 Cancer Res. pmid:2917351
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Ban M et al. A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. 1989 Stroke pmid:2919414
Goto H et al. The role of prostaglandin D2 in the genesis of indomethacin-induced gastric lesions in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595317
Busshardt E et al. Regulation of hepatic parenchymal and non-parenchymal cell function by the diadenine nucleotides Ap3A and Ap4A. 1989 Biochim. Biophys. Acta pmid:2563228
Salari H and Chan-Yeung M Interleukin-1 potentiates antigen-mediated arachidonic acid metabolite formation in mast cells. 1989 Clin. Exp. Allergy pmid:2513105
Chakraborti S et al. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium. 1989 Am. J. Physiol. pmid:2514605
Triggiani M et al. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468619
Charlesworth EN et al. Cells and secretagogues involved in the human late-phase response. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468620
Church MK et al. Interaction of neuropeptides with human mast cells. 1989 Int. Arch. Allergy Appl. Immunol. pmid:2468622
Charlesworth EN et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. 1989 J. Clin. Invest. pmid:2468688
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Church MK et al. Mast cells, neuropeptides and inflammation. 1989 Agents Actions pmid:2473641
van Overveld FJ Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. 1989 Agents Actions pmid:2473645
Benyon RC et al. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. 1989 Br. J. Pharmacol. pmid:2474353
Dubertret L et al. Biological and cellular responses to grass pollen in sensitive patients. 1989 Dermatologica pmid:2476344
Wachs M et al. Observations on the pathogenesis of nasal priming. 1989 J. Allergy Clin. Immunol. pmid:2477429
Robinson C et al. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. 1989 J. Invest. Dermatol. pmid:2504819
Giles H et al. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. 1989 Br. J. Pharmacol. pmid:2924081
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Hayaishi O Prostaglandin D2 and sleep. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526481
Watanabe Y et al. Positron emission tomography studies using [11C]ester of prostaglandin D2. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526503
Morrow JD et al. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. 1989 Prostaglandins pmid:2475889
Fukushima M et al. Prostaglandin A and J: antitumor and antiviral prostaglandins. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526507
Thierauch KH et al. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526554
Gray PR et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. 1989 Am. Rev. Respir. Dis. pmid:2502051
Dieter P et al. 4-Bromophenacyl bromide inhibits prostaglandin D2 synthesis from arachidonic acid rather than phospholipase A2 activity in liver macrophages. 1989 Biol. Chem. Hoppe-Seyler pmid:2775481
Coe JY et al. A fetal-instrumented model to study age-specific responses to leukotriene D4 and prostaglandin D2 in unsedated newborn lambs. 1989 Can. J. Physiol. Pharmacol. pmid:2776077
Ehara H [An experimental study on antitumor effect of prostaglandin D2]. 1989 Nihon Geka Gakkai Zasshi pmid:2796985
Thierauch KH et al. ZK 110 841--a selective and potent prostaglandin D2 analogue. 1989 Prog. Clin. Biol. Res. pmid:2798462
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Raisz LG and Woodiel FN Effect of alterations in the cyclopentane ring on bone resorptive activity of prostaglandin. 1989 Prostaglandins pmid:2727307
Wolfe LS et al. Metabolism of prostaglandin D2 by human cerebral cortex into 9 alpha, 11 beta-prostaglandin F2 by an active NADPH-dependent 11-ketoreductase. 1989 J. Neurochem. pmid:2723663
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083
Marone G Control mechanisms of mediator release in human basophils and mast cells. 1988 Nov-Dec Immunol. Invest. pmid:2465995
Hayaishi O Sleep-wake regulation by prostaglandins D2 and E2. 1988 J. Biol. Chem. pmid:3049580
Iwai M et al. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver. 1988 Eur. J. Biochem. pmid:3165341
Tran-Thi TA et al. Net prostaglandin release by perfused rat liver after stimulation with phorbol 12-myristate 13-acetate. 1988 J. Hepatol. pmid:3166024
Parsons WG and Roberts LJ Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. 1988 J. Immunol. pmid:3139758
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
Fukui A et al. Effects of prostaglandin D2 and omeprazole on indomethacin-induced gastric ulcers in rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3149561
Vigano T et al. Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma. 1988 Eicosanoids pmid:3152489
Casteleijn E et al. Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. 1988 Biochem. J. pmid:3162673
Ishioka C et al. Inhibitory effects of prostaglandin A2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. 1988 Cancer Res. pmid:3162825
Soifer SJ et al. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. 1988 J. Pediatr. pmid:3162978
Ujihara M et al. Biochemical and immunological demonstration of prostaglandin D2, E2, and F2 alpha formation from prostaglandin H2 by various rat glutathione S-transferase isozymes. 1988 Arch. Biochem. Biophys. pmid:3041912
Chock SP and Schmauder-Chock EA Synthesis of prostaglandins and eicosanoids by the mast cell secretory granule. 1988 Biochem. Biophys. Res. Commun. pmid:3190706
Rodriguez y Baena R et al. A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. 1988 J. Neurol. Sci. pmid:3132538